Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab vs Methotrexate Mechanism of Action in Psoriasis
NCT00932113Phase 4Completed
- Sponsor
- Tufts Medical Center
- Start
- Jun 2009
- Primary completion
- Dec 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in psoriasis, sponsored by Tufts Medical Center. Started Jun 2009; status: completed.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00932113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00932113.